Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Klaus Grywna is active.

Publication


Featured researches published by Klaus Grywna.


Emerging Infectious Diseases | 2008

Chikungunya fever in travelers returning to Europe from the Indian Ocean region, 2006.

Marcus Panning; Klaus Grywna; Marjan Van Esbroeck; Petra Emmerich; Christian Drosten

Chikungunya fever should be added to the list of differential diagnoses for ill travelers returning from this region.


Emerging Infectious Diseases | 2008

Detection and Prevalence Patterns of Group I Coronaviruses in Bats, Northern Germany

Florian Gloza-Rausch; Anne Ipsen; Antje Seebens; Matthias Göttsche; Marcus Panning; Jan Felix Drexler; Nadine Petersen; Augustina Annan; Klaus Grywna; Marcel A. Müller; Susanne Pfefferle; Christian Drosten

The virus is probably maintained on the population level by amplification and transmission in maternity colonies.


Journal of Clinical Microbiology | 2008

Prevalence, Types, and RNA Concentrations of Human Parechoviruses, Including a Sixth Parechovirus Type, in Stool Samples from Patients with Acute Enteritis

Sigrid Baumgarte; Luciano Kleber de Souza Luna; Klaus Grywna; Marcus Panning; Jan Felix Drexler; Claudia Karsten; Hans Iko Huppertz; Christian Drosten

ABSTRACT Parechovirus epidemiology and disease association are not fully understood. Real-time reverse transcriptase PCR (RT-PCR) for all human parechoviruses (HPeV) was applied on stool samples from two groups of patients. Both groups contained patients with acute enteritis of all age groups, seen during one full year. Patients with norovirus, adenovirus, enterovirus, astrovirus, or rotavirus infections were excluded. In 118 patients from outbreak and hospital settings, no HPeV was detected. In a prospective study group of 499 nonhospitalized patients, the detection rate was 1.6%. One virus-positive patient was detected from 39 control patients. Positive samples occurred only in summer and autumn. Only one patient had accompanying respiratory symptoms. An association with travel or animal contact was not found. All positive patients except one were <2 years of age, with a neutral gender ratio. In children <2 years of age, the detection rate was 11.6% (7 of 60 children). The range of viral loads was 3,170 to 503,377,290 copies per gram or milliliter of stool. One of the highest viral loads occurred in a control child without symptoms at the time of testing. Phylogenetic analysis showed mainly contemporary HPeV1 strains in our patients but also showed a separate new lineage of HPeV1 in evolutionary transition from the historical prototype strain. Moreover, a novel sixth HPeV type was identified. Full genome analysis of the two viruses revealed recombination between HPeV1 and -3 in one and HPeV6 and -1 in another. HPeV seems relevant in children <2 years and specific RT-PCR for HPeV should be included in enteritis screening.


Emerging Infectious Diseases | 2009

Novel Human Parechovirus from Brazil

Jan Felix Drexler; Klaus Grywna; Andreas Stöcker; Patrícia Silva Almeida; Tereza Cristina Medrado Ribeiro; Monika Eschbach-Bludau; Nadine Petersen; Hugo Ribeiro; Christian Drosten

Human parechoviruses (HPeVs) were detected by reverse transcription–PCR in 16.1% of 335 stool samples from children <6 years of age with enteritis in Salvador, Brazil. Whole genome sequencing of 1 sample showed a novel HPeV that has been designated as HPeV8.


Emerging Infectious Diseases | 2007

Coronavirus Antibodies in African Bat Species

Marcel A. Müller; Janusz T. Paweska; Patricia A. Leman; Christian Drosten; Klaus Grywna; Alan Kemp; Leo Braack; Karen Sonnenberg; Matthias Niedrig; Robert Swanepoel

Asian bats have been identified as potential reservoir hosts of coronaviruses associated with severe acute respiratory syndrome (SARS-CoV). We detected antibody reactive with SARS-CoV antigen in 47 (6.7%) of 705 bat serum specimens comprising 26 species collected in Africa; thus, African bats may harbor agents related to putative group 4 CoV.


Journal of General Virology | 2010

Recombination dynamics of human parechoviruses: investigation of type-specific differences in frequency and epidemiological correlates.

J. Calvert; Thaweesak Chieochansin; Kimberley Benschop; E. C. McWilliam Leitch; J. F. Drexler; Klaus Grywna; H. da Costa Ribeiro; Christian Drosten; Heli Harvala; Yong Poovorawan; Katja C. Wolthers; Peter Simmonds

Human parechoviruses (HPeVs) are highly prevalent RNA viruses classified in the family Picornaviridae. Several antigenically distinct types circulate in human populations worldwide, whilst recombination additionally contributes to the genetic heterogeneity of the virus. To investigate factors influencing the likelihood of recombination and to compare its dynamics among types, 154 variants collected from four widely geographically separated referral centres (UK, The Netherlands, Thailand and Brazil) were typed by VP3/VP1 amplification/sequencing with recombination groups assigned by analysis of 3Dpol sequences. HPeV1B and HPeV3 were the most frequently detected types in each referral region, but with marked geographical differences in the frequencies of different recombinant forms (RFs) of types 1B, 5 and 6. HPeV1B showed more frequent recombination than HPeV3, in terms both of evolutionary divergence and of temporal/geographical indicators of population separation. HPeV1 variants showing between 10 and 20% divergence in VP3/VP1 almost invariably fell into different recombination groups, compared with only one-third of similarly divergent HPeV3 variants. Substitution rates calculated by beast in the VP3/VP1 region of HPeV1 and HPeV3 allowed half-lives of the RFs of 4 and 20 years, respectively, to be calculated, estimates fitting closely with their observed lifespans based on population sampling. The variability in recombination dynamics between HPeV1B and HPeV3 offers an intriguing link with their markedly different seasonal patterns of transmission, age distributions of infection and clinical outcomes. Future investigation of the epidemiological and biological opportunities and constraints on intertypic recombination will provide more information about its influence on the longer term evolution and pathogenicity of parechoviruses.


PLOS Medicine | 2009

A Novel Diagnostic Target in the Hepatitis C Virus Genome

Jan Felix Drexler; Bernd Kupfer; Nadine Petersen; Rejane Maria Tommasini Grotto; Silvia Maria Corvino Rodrigues; Klaus Grywna; Marcus Panning; Augustina Annan; Giovanni Faria Silva; Jill Douglas; Evelyn Siew-Chuan Koay; Heidi Smuts; Eduardo Martins Netto; Peter Simmonds; Maria Inês de Moura Campos Pardini; W. Kurt Roth; Christian Drosten

Background Detection and quantification of hepatitis C virus (HCV) RNA is integral to diagnostic and therapeutic regimens. All molecular assays target the viral 5′-noncoding region (5′-NCR), and all show genotype-dependent variation of sensitivities and viral load results. Non-western HCV genotypes have been under-represented in evaluation studies. An alternative diagnostic target region within the HCV genome could facilitate a new generation of assays. Methods and Findings In this study we determined by de novo sequencing that the 3′-X-tail element, characterized significantly later than the rest of the genome, is highly conserved across genotypes. To prove its clinical utility as a molecular diagnostic target, a prototype qualitative and quantitative test was developed and evaluated multicentrically on a large and complete panel of 725 clinical plasma samples, covering HCV genotypes 1–6, from four continents (Germany, UK, Brazil, South Africa, Singapore). To our knowledge, this is the most diversified and comprehensive panel of clinical and genotype specimens used in HCV nucleic acid testing (NAT) validation to date. The lower limit of detection (LOD) was 18.4 IU/ml (95% confidence interval, 15.3–24.1 IU/ml), suggesting applicability in donor blood screening. The upper LOD exceeded 10−9 IU/ml, facilitating viral load monitoring within a wide dynamic range. In 598 genotyped samples, quantified by Bayer VERSANT 3.0 branched DNA (bDNA), X-tail-based viral loads were highly concordant with bDNA for all genotypes. Correlation coefficients between bDNA and X-tail NAT, for genotypes 1–6, were: 0.92, 0.85, 0.95, 0.91, 0.95, and 0.96, respectively; X-tail-based viral loads deviated by more than 0.5 log10 from 5′-NCR-based viral loads in only 12% of samples (maximum deviation, 0.85 log10). The successful introduction of X-tail NAT in a Brazilian laboratory confirmed the practical stability and robustness of the X-tail-based protocol. The assay was implemented at low reaction costs (US


The Journal of Infectious Diseases | 2007

Spectrum of Viruses and Atypical Bacteria in Intercontinental Air Travelers with Symptoms of Acute Respiratory Infection

Luciano Kleber de Souza Luna; Marcus Panning; Klaus Grywna; Susanne Pfefferle; Christian Drosten

8.70 per sample), short turnover times (2.5 h for up to 96 samples), and without technical difficulties. Conclusion This study indicates a way to fundamentally improve HCV viral load monitoring and infection screening. Our prototype assay can serve as a template for a new generation of viral load assays. Additionally, to our knowledge this study provides the first open protocol to permit industry-grade HCV detection and quantification in resource-limited settings.


Virology Journal | 2008

Identification of a contemporary human parechovirus type 1 by VIDISCA and characterisation of its full genome.

Luciano Kleber de Souza Luna; Sigrid Baumgarte; Klaus Grywna; Marcus Panning; Jan Felix Drexler; Christian Drosten

Abstract Respiratory infections after air travel are frequent, but epidemiological data are incomplete. Using sensitive polymerase chain reactions, we studied the spectrum of atypical bacteria and respiratory viruses in travelers fulfilling the case definition of severe acute respiratory syndrome. A pathogen was identified in 67 travelers (43.2%). Influenza and parainfluenza viruses were most prevalent, at 14.2% and 15.5%, respectively. Prevalences of adenoviruses, human metapneumovirus, coronaviruses, and rhinoviruses ranged between 2.6% and 4.8%. Human bocavirus, respiratory syncytial virus, and Legionella, Mycoplasma, and Chlamydophila species were absent or appeared at frequencies of <1%. To our knowledge, these are the first specific baseline data for the mentioned agents in the context of air travel.


Virology Journal | 2009

Reverse genetic characterization of the natural genomic deletion in SARS-Coronavirus strain Frankfurt-1 open reading frame 7b reveals an attenuating function of the 7b protein in-vitro and in-vivo

Susanne Pfefferle; Verena Krähling; Vanessa Ditt; Klaus Grywna; Elke Mühlberger; Christian Drosten

BackgroundEnteritis is caused by a spectrum of viruses that is most likely not fully characterised. When testing stool samples by cell culture, virus isolates are sometimes obtained which cannot be typed by current methods. In this study we used VIDISCA, a virus identification method which has not yet been widely applied, on such an untyped virus isolate.ResultsWe found a human parechovirus (HPeV) type 1 (strain designation: BNI-788st). Because genomes of contemporary HPeV1 were not available, we determined its complete genome sequence. We found that the novel strain was likely the result of recombination between structural protein genes of an ancestor of contemporary HPeV1 strains and nonstructural protein genes from an unknown ancestor, most closely related to HPeV3. In contrast to the non-structural protein genes of other HPeV prototype strains, the non-structural protein genes of BNI-788st and HPeV3 prototype strains did not co-segregate in bootscan analysis with that of other prototype strains.ConclusionHPeV3 nonstructural protein genes may form a distinct element in a pool of circulating HPeV non-structural protein genes. More research into the complex HPeV evolution is required to connect virus ecology with disease patterns in humans.

Collaboration


Dive into the Klaus Grywna's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jan Felix Drexler

Humboldt University of Berlin

View shared research outputs
Top Co-Authors

Avatar

Augustina Annan

Bernhard Nocht Institute for Tropical Medicine

View shared research outputs
Top Co-Authors

Avatar

Luciano Kleber de Souza Luna

Bernhard Nocht Institute for Tropical Medicine

View shared research outputs
Top Co-Authors

Avatar

Nadine Petersen

Bernhard Nocht Institute for Tropical Medicine

View shared research outputs
Top Co-Authors

Avatar

Susanne Pfefferle

Bernhard Nocht Institute for Tropical Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Petra Emmerich

Bernhard Nocht Institute for Tropical Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge